Clinical trial
PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient
NCT03295695
Study timeline
Study start (estimated)2020-12-01Date precision: month
Registry last updated2020-12-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Breast Cancer, Femaleunresolved
Breast Cancer, Maleunresolved
Breast Neoplasmsunresolved
Interventions
Fluoro-D-glucose-positron Emission TomographyDIAGNOSTIC_TEST
2-deoxy-2-[18F]fluoro-D-glucose (FDG)BIOLOGICAL
EchocardiogramDIAGNOSTIC_TEST
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03295695 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.